Reserve samples are one of those GMP requirements that manufacturers tend to underestimate until an FDA investigator shows up and starts asking for them. The regulation itself is compact — 21 CFR 111.83 runs just a few paragraphs — but the compliance gaps it exposes can be substantial, especially for smaller manufacturers who have never been inspected.
This guide walks through every clause-level requirement in 21 CFR 111.83, explains the intent behind each one, and gives you the practical detail you need to build a defensible reserve sample program from scratch or tighten up an existing one.
What Is 21 CFR 111.83 and Why Does It Exist?
Under FDA's dietary supplement Current Good Manufacturing Practice regulations at 21 CFR Part 111, reserve samples serve one purpose: they give you — and FDA — the ability to go back and investigate a batch after it has left your facility. If a consumer complaint surfaces six months after distribution, or if an adverse event triggers a regulatory inquiry, reserve samples are the physical evidence that allows you to retest the batch, compare against original certificates of analysis, and reconstruct what happened.
Without them, you are essentially asking FDA to take your word for it. That is not a position you want to be in during an inspection or a recall investigation.
21 CFR 111.83 sits within Subpart E (Requirement to Establish a Production and Process Control System), which establishes the production and process control requirements that support your quality system. Reserve samples are specifically addressed in the "Reserve samples" subsection, and they apply to both finished dietary supplements you manufacture and to any dietary supplement components you receive that are used in manufacturing.
The Full Regulatory Text: Clause-by-Clause
21 CFR 111.83(a) and (b)(1) — What You Must Retain
The regulation requires you to collect and retain reserve samples of each lot of dietary supplement you distribute. The sample must be:
- Collected from the same lot used for distribution
- Retained in the same immediate container-closure system as the product that is distributed, OR in one that provides essentially the same characteristics, per 111.83(b)(1)
That second option — "essentially the same characteristics" — is not a wide-open door. FDA expects the alternative container to protect the sample from the same environmental factors (light, moisture, oxygen) as the commercial packaging. If your product is in a foil-sealed amber HDPE bottle, a clear plastic bag is not an equivalent container. Document your rationale in a written procedure if you use an alternative.
21 CFR 111.83(b)(4) — Quantity Requirements
This is where most manufacturers get into trouble. The regulation at 21 CFR 111.83(b)(4) requires that the quantity retained be at least twice the amount necessary to perform all the required tests or examinations to determine whether the dietary supplement meets all specifications.
Work through the math before you establish your reserve sample quantity. If your finished product specification requires:
- Identity testing (HPLC): 2g
- Heavy metals (ICP-MS): 1g
- Microbiological testing: 10g
- Moisture: 2g
Then a single full round of testing requires 15g, and your reserve sample minimum is 30g — double that. If your dosage form is a 1g softgel, you need at least 30 softgels per lot in reserve. Many manufacturers set their standard at 2–3 times the testing quantity to build in buffer for additional investigations.
21 CFR 111.83(b)(3) — Retention Period
Under 21 CFR 111.83(b)(3), reserve samples must be kept for one year past the shelf life date of the dietary supplement, if a shelf life date is included on the label. For products without a shelf life date, they must be kept for two years beyond the date of distribution of the last batch of product associated with the reserve sample.
This is a distinction worth slowing down on. If your product label carries an expiration or best-by date, your retention clock starts from that date. If it does not, your clock starts from the last distribution date of that lot. Both endpoints require accurate, searchable records — you need to be able to locate and produce any reserve sample on demand.
Storage Conditions for Reserve Samples
21 CFR 111.83 runs only to subsections (a) and (b)(1)-(4) — there is no separate storage-conditions clause. What 111.83(b)(1) actually requires is that reserve samples be held in the same container-closure system as the distributed product, or one that provides essentially the same characteristics, specifically to protect against contamination or deterioration. Meeting that intent in practice means storing reserve samples under conditions consistent with the product label, or under conditions appropriate for the product if no specific storage conditions are stated on the label. This seems straightforward, and usually is — but two common failure modes are worth flagging:
-
Reserve samples stored in a different environment than the product label states. If the label says "store below 25°C / 77°F," your reserve sample storage area must meet that spec. Storing samples in a room that regularly exceeds that temperature isn't compliant, even if the samples were pulled correctly in every other respect.
-
Environmental monitoring records that don't cover the reserve sample area. If your temperature monitoring program covers your warehouse and your finished goods area but not your reserve sample cabinet or room, FDA will notice.
Periodic Visual Examination — Best Practice
Although 21 CFR Part 111 does not include an explicit annual visual examination requirement for dietary supplement reserve samples (that obligation appears in 21 CFR 211.170, which governs finished pharmaceuticals), periodic visual examination is widely recognized as a sound quality practice and is consistent with the broader GMP obligation to maintain reserve samples in a usable, investigable condition.
A written examination procedure should address:
- Examination frequency (annually is a common and defensible interval)
- Who is authorized to conduct the examination
- What criteria constitute deterioration (e.g., discoloration, crystal formation, capsule softening, label degradation)
- What happens when deterioration is observed — your investigation and CAPA process
Documenting these examinations supports your ability to demonstrate the integrity of retained samples if they are called upon during an investigation or inspection.
Component Sampling Under 21 CFR Part 111
While 21 CFR 111.83 governs finished product reserve samples, 21 CFR Part 111 also imposes representative sampling requirements for components, in-process materials, and finished batches under Subpart E. Notably, 21 CFR 111.80 governs what representative samples must be collected for QC purposes — it is not a reserve-sample retention rule and does not mirror 111.83's quantity-and-retention structure.
Manufacturers should review their component sampling procedures against the specific requirements of Subpart E and consult the full regulatory text to ensure those procedures are scoped correctly. Where component reserve samples are maintained as a quality practice, it is reasonable to document the rationale and methodology in your SOP, clearly distinguishing them from finished product reserves held under 111.83.
Building a Compliant Reserve Sample Program: Step-by-Step
Step 1 — Write a Reserve Sample SOP
Your Standard Operating Procedure needs to cover, at minimum:
- Scope (finished product, components, or both)
- Sampling point in the manufacturing process (typically after final packaging)
- How quantity is calculated per lot and per product
- Container requirements and labeling requirements
- Storage location and conditions
- Retention period calculation methodology
- Annual visual examination procedure and documentation requirements
- What to do with samples after the retention period expires
- How reserve samples are accessed for investigation
Step 2 — Calculate Reserve Sample Quantities for Each Product
Do this calculation product by product, not generically. Create a reserve sample quantity table that lists each product, the full set of specifications it must be tested against, the quantity required for each test, the total testing quantity, and the required reserve quantity (2x). Keep this as a controlled document and update it whenever specifications change.
Step 3 — Design Your Reserve Sample Label
Every reserve sample container must be labeled to allow unambiguous identification. At minimum, label each container with:
- Product name
- Lot number
- Date collected
- Quantity
- Storage requirements
- Retention period expiration date
Some manufacturers also include the batch record number or the CoA reference. More information is better here — the label is what allows someone to correctly identify and retrieve the sample two years later.
Step 4 — Establish a Dedicated Storage Area
Avoid mixing reserve samples with in-process or released inventory. A dedicated cabinet, shelf section, or room makes inventory management cleaner and prevents accidental use of reserve samples. Confirm that the area is covered by your environmental monitoring program.
Step 5 — Set Up a Retention Period Tracking System
This can be as simple as a spreadsheet with a column for the retention period expiration date and a flag for samples approaching that date, or it can be integrated into your QMS software. The important thing is that someone reviews the tracker regularly and initiates a formal disposition process — not just discards samples ad hoc.
Step 6 — Schedule and Document Annual Visual Examinations
Add a recurring annual task to your quality calendar. Assign responsibility clearly. Create a form or log for recording examination results by lot number. When deterioration is found, document it and initiate your investigation process.
Reserve Sample Requirements: Quick Reference Table
| Requirement | 21 CFR Clause | Specification |
|---|---|---|
| Finished product reserve samples | 111.83(a) | Required for each distributed lot |
| Component sampling (QC representative samples) | 111.80 | Governs representative sampling for QC purposes; not a reserve-sample retention rule and does not mirror 111.83's quantity-and-retention structure |
| Quantity — finished product | 111.83(b)(4) | 2x the amount needed to perform all required tests |
| Retention period — labeled shelf life | 111.83(b)(3) | 1 year beyond the shelf life date on the label |
| Retention period — no shelf life date | 111.83(b)(3) | 2 years beyond date of distribution of last lot |
| Storage conditions (best practice; supports 111.83(b)(1)'s contamination/deterioration protection) | Not a standalone 111.83 clause | Consistent with product label or appropriate to product |
| Periodic visual examination (best practice, not required by 111.83) | Not a numbered Part 111 requirement | Recommended at least once per year, with documentation |
| Container type | 111.83(b)(1) | Same as commercial, or essentially equivalent characteristics |
Common FDA Inspection Findings Related to Reserve Samples
FDA Form 483 observations and Warning Letters related to dietary supplement GMPs are publicly available on FDA's website, and reserve sample deficiencies appear with regularity. Common patterns include:
Insufficient quantity. The manufacturer retained samples but did not calculate the quantity correctly — often because they only accounted for one round of testing instead of doubling it. A single extra test request blows the reserve supply.
No periodic visual examination records. Samples were collected and stored, but no documented examination procedure was in place or followed. While Part 111 does not specify an explicit examination interval, the absence of any examination records leaves a manufacturer unable to demonstrate that retained samples remained in usable condition.
Storage conditions not matching the label. Reserve samples stored at ambient room temperature for products that specify refrigeration, or stored in a room without documented temperature monitoring.
Inadequate container labeling. Samples in unlabeled or minimally labeled bags that make lot-number traceability difficult. An investigator who cannot confidently link a reserve sample to a specific lot record has reason to document a deficiency.
No defined retention period or retention calculation. The manufacturer retained samples but had no written procedure specifying when they expire or how that date is calculated.
Reserve Sample Checklist
Use this as a self-audit tool before your next inspection.
- [ ] Written reserve sample SOP exists and is currently approved
- [ ] SOP covers finished product reserve samples under 111.83; component sampling procedures address Subpart E requirements separately
- [ ] Reserve sample quantity is calculated as 2x the full testing quantity for each product
- [ ] Quantity calculation is documented per product and updated when specs change
- [ ] Reserve samples are collected from the same lot as distributed product
- [ ] Container type matches commercial packaging or equivalence is documented
- [ ] Each reserve sample container is labeled with product name, lot number, collection date, quantity, storage requirements, and retention expiration date
- [ ] Storage area conditions are consistent with product label requirements
- [ ] Storage area is included in environmental monitoring program
- [ ] Retention period is tracked in a system that allows retrieval on demand
- [ ] Procedure for periodic visual examination of retained samples is documented in the SOP
- [ ] Visual examination records exist for all retained lots
- [ ] Deterioration observations trigger a documented investigation process
- [ ] Samples at or near retention period expiration have a formal disposition process
How Reserve Samples Connect to the Rest of Your Quality System
Reserve samples do not exist in isolation. They are one piece of a broader laboratory controls framework that includes your specifications (21 CFR 111.70), your laboratory operations (21 CFR 111.310), and your product complaint handling (21 CFR 111.560). When a complaint comes in alleging that a product caused illness or injury, the reserve sample is what allows you to test the retained lot and determine whether the batch met specifications at the time of distribution. That investigation, in turn, feeds your CAPA process and your adverse event reporting obligations.
A reserve sample program that is technically compliant on paper but practically inaccessible — because records are disorganized, samples are mislabeled, or the storage area is chaotic — provides almost no value when you actually need it. The compliance value and the operational value are the same thing.
For manufacturers who are building out a full dietary supplement GMP program, reserve samples are one of several systems that need to be designed together rather than in sequence. I have written a broader overview of how to build a GMP-compliant operation from the ground up if you want the full context.
If you want hands-on support designing or auditing your reserve sample program specifically, the dietary supplement GMP consulting services at Certify Consulting are built around exactly this kind of clause-level work.
Last updated: 2026-09-15
Frequently Asked Questions
How much reserve sample does 21 CFR 111.83 require me to keep?
21 CFR 111.83(b) requires you to retain at least twice the quantity needed to perform all required tests or examinations to determine whether the dietary supplement meets all of its specifications. Calculate your full testing quantity across every spec in your finished product specification, then double it. That is the minimum per lot.
How long do I need to keep reserve samples under 21 CFR 111.83?
If your product label includes a shelf life date, you must retain reserve samples for one year past that date. If your product has no shelf life date on the label, retain samples for three years beyond the date of distribution of the last lot associated with the sample. Both scenarios require accurate distribution records to calculate the retention end date correctly.
Can I store reserve samples in a different container than the commercial packaging?
Yes, but only in a container that provides essentially the same characteristics as the commercial packaging. The alternative container must protect the sample from the same environmental factors — light, moisture, oxygen, temperature — as the original. If you use an alternative container, document the rationale and equivalency determination in your reserve sample SOP.
What happens during a reserve sample visual examination?
Under 21 CFR 111.83(e), you must visually examine reserve samples at least once a year and document the examination. Your SOP should define who conducts the examination, what criteria constitute deterioration for your specific dosage forms, and what investigation process is triggered when deterioration is observed. Records must be maintained for each lot examined.
Does 21 CFR 111.83 apply to raw material components as well as finished products?
Finished product reserve samples are governed by 21 CFR 111.83. Component reserve samples — for raw materials and dietary ingredients used in manufacturing — are governed by the parallel requirement at 21 CFR 111.80. The quantity and retention period structure is essentially the same for both: retain twice the testing quantity, and keep samples for one year past the finished product shelf life date or three years past the last distribution date.
Jared Clark
GMP Compliance Consultant, Certify Consulting
Jared Clark is a GMP compliance consultant and founder of Certify Consulting, specializing in FDA GMP requirements for pharmaceuticals, dietary supplements, cosmetics, and food manufacturing.